Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy
- PMID: 23702124
- PMCID: PMC3664954
- DOI: 10.1016/j.cll.2013.01.001
Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy
Abstract
Knowledge of antiphospholipid antibodies and their impact on pregnancy continues to evolve. A variety of antiphospholipid antibodies have been identified, but not all of them seem to be pathologic for pregnancy outcome. Understanding of which patients are at high risk for adverse pregnancy outcome and the most effective treatment will require clinical trials based on risk stratification and long-term follow-up of infants.
Copyright © 2013 Elsevier Inc. All rights reserved.
References
-
- Wassermann A, Neisser A, Bruck C. Eine serodiagnostische Reaktion bei Syphilis. [December 24, 2012];Deutsche medicinische Wochenschrift, Berlin. 1906 32:745–6. http://en.wikipedia.org/wiki/Wassermann_test.
-
- Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Lab Clin Invest. 1952;31:621–2.
-
- Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med. 1980;92:156–9. - PubMed
-
- Bowie EJW, Thompson JH, Pascuzzi CA, et al. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med. 1963;62:416–430. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical